Immunovia AB (OSTO:IMMNOV)
kr 1.246 0.401 (47.46%) Market Cap: 210.93 Mil Enterprise Value: 182.88 Mil PE Ratio: 0 PB Ratio: 5.77 GF Score: 36/100

Q4 2021 Immunovia AB (publ) Earnings Call Transcript

Feb 17, 2022 / 09:00AM GMT
Release Date Price: kr17.03 (-21.84%)
Operator

Welcome to the Immunovia Audiocast with Teleconference Q4 2021. We apologize for the delay. We had a technical issue. The right phone number is on the speaker picture. (Operator Instructions)

Today, I am pleased to present CEO, Philipp Mathieu. Sir, please go ahead.

Tobias Bülow;publ;Senior Director IR;Corporate Communications
Immunovia AB

()-&

Good morning, and warm welcome to Immunovia's fourth quarter 2021. My name is Tobias Bülow, and I'm heading Investor Relations. With me today here in Lund are the Immunovia President and CEO, Philipp Mathieu. When we move over to the Q&A session, he will also be joined by our Medical Director, Thomas King. (Operator Instructions) We will end at latest 11. And for your information, this session will also be uploaded as on demand on the web.

With that, I hand over to Philipp.

Philipp Mathieu;publ;Acting CEO;President
Immunovia AB

()-&

Thank you very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot